Analysis of the CD34+ cell to total nucleated cell content ratio of 619 transplanted and back-up cord blood units

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: CD34+ cell to TNC content (CD34+/TNC) ratio in units selected for adult CBT recipients at MSKCC between 2014 and 2019.

References

  1. 1.

    Barker JN, Boughan K, Dahi PB, Devlin SM, Maloy MA, Naputo K, et al. Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis. Blood Adv. 2019;3:939–44. https://doi.org/10.1182/bloodadvances.2018028662.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Barker JN, Mazis CM, Devlin SM, Davis E, Maloy MA, Naputo K, et al. Evaluation of cord blood total nucleated and CD34(+) cell content, cell dose, and 8-allele HLA match by patient ancestry. Biol Blood Marrow Transplant. 2020;26:734–44. https://doi.org/10.1016/j.bbmt.2019.11.017.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Barker JN, Kurtzberg J, Ballen K, Boo M, Brunstein C, Cutler C, et al. Optimal practices in unrelated donor cord blood transplantation for hematologic malignancies. Biol Blood Marrow Transplant. 2017;23:882–96. https://doi.org/10.1016/j.bbmt.2017.03.006.

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Dehn J, Spellman S, Hurley CK, Shaw BE, Barker JN, Burns LJ, et al. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. Blood. 2019;134:924–34. https://doi.org/10.1182/blood.2019001212.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Purtill D, Smith K, Devlin S, Meagher R, Tonon J, Lubin M, et al. Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice. Blood. 2014;124:2905–12.

    CAS  Article  Google Scholar 

  6. 6.

    Konuma T, Kato S, Oiwa-Monna M, Tanoue S, Ogawa M, Isobe M, et al. Cryopreserved CD34(+) cell dose, but not total nucleated cell dose, influences hematopoietic recovery and extensive chronic graft-versus-host disease after single-unit cord blood transplantation in adult patients. Biol Blood Marrow Transplant. 2017;23:1142–50. https://doi.org/10.1016/j.bbmt.2017.03.036.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–8. https://doi.org/10.1182/blood-2002-01-0294.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Barker JN, Kempenich J, Kurtzberg J, Brunstein CG, Delaney C, Milano F, et al. CD34(+) cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking. Blood Adv. 2019;3:1267–71. https://doi.org/10.1182/bloodadvances.2018029157.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Spellman S, Hurley CK, Brady C, Phillips-Johnson L, Chow R, Laughlin M, et al. Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood. Cytotherapy. 2011;13:848–55. https://doi.org/10.3109/14653249.2011.571249.

    Article  PubMed  Google Scholar 

  10. 10.

    Ponce DM, Lubin M, Gonzales AM, Byam C, Wells D, Ferrante R, et al. The use of back-up units to enhance the safety of unrelated donor cord blood transplantation. Biol Blood Marrow Transplant. 2012;18:648–51. https://doi.org/10.1016/j.bbmt.2011.12.588.

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Moroff G, Eichler H, Brand A, Kekomaki R, Kurtz J, Letowska M, et al. Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood. Transfusion. 2006;46:507–15. https://doi.org/10.1111/j.1537-2995.2006.00758.x.

    Article  PubMed  Google Scholar 

  12. 12.

    Flores AI, McKenna DH, Montalban MA, De la Cruz J, Wagner JE, Bornstein R. Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: results of a pairwise analysis of umbilical cord blood units and cryopreserved aliquots. Transfusion. 2009;49:636–47. https://doi.org/10.1111/j.1537-2995.2008.02035.x.

    Article  PubMed  Google Scholar 

  13. 13.

    Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213–26. https://doi.org/10.1089/scd.1.1996.5.213.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Akyurekli C, Chan JY, Elmoazzen H, Tay J, Allan DS. Impact of ethnicity on human umbilical cord blood banking: a systematic review. Transfusion. 2014;54:2122–7. https://doi.org/10.1111/trf.12630.

    Article  PubMed  Google Scholar 

  15. 15.

    Cairo MS, Wagner EL, Fraser J, Cohen G, van de Ven C, Carter SL, et al. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report. Transfusion. 2005;45:856–66. https://doi.org/10.1111/j.1537-2995.2005.04429.x.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported in part by a grant from the National Institute of Health, National Cancer Institute (P30 CA008748).

Author information

Affiliations

Authors

Contributions

IP, AS, and JNB designed the study, analyzed the data, and wrote the paper. IP performed the statistical analysis. CMM, KAN, KS, MN, and ED collected and analyzed the data. All authors reviewed and approved the final version of the paper.

Corresponding author

Correspondence to Ioannis Politikos.

Ethics declarations

Conflict of interest

IP has received an educational grant from Merck and serves on a Data and Safety Monitoring Board (DSMB) for ExCellThera. AS has served as the Medical Director at the New York Blood Center/National Cord Blood Program and serves on a DSMB for ExCellThera. JNB has received clinical trial funding from Angiocrine Bioscience and unrestricted educational grants from Gamida Cell and Merck. The authors have no other relevant conflicts of interest to declare.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Politikos, I., Mazis, C.M., Naputo, K.A. et al. Analysis of the CD34+ cell to total nucleated cell content ratio of 619 transplanted and back-up cord blood units. Bone Marrow Transplant (2020). https://doi.org/10.1038/s41409-020-01042-7

Download citation

Further reading

  • Guidelines for Cord Blood Unit Selection

    • Ioannis Politikos
    • , Eric Davis
    • , Melissa Nhaissi
    • , John E. Wagner
    • , Claudio G. Brunstein
    • , Sandra Cohen
    • , Elizabeth J. Shpall
    • , Filippo Milano
    • , Andromachi Scaradavou
    •  & Juliet N. Barker

    Biology of Blood and Marrow Transplantation (2020)

Search